Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Name / Ticker | Price | Zen Rating |
---|---|---|
$46.39 | A | |
$7.82 | A | |
$60.81 | A |